Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI Biotech Holding ASA.

You May Also Be Interested In

• Aetna Tops Corporate Insight’s 2026 Health Plan Experience Benchmarks for Member Website and Mobile App
• PointFive Joins the Tokenomics Foundation as a Premier Member and Takes a Seat on the Governing Board
• China Chunlai Education Group to Acquire Dublin Business School From Kaplan